MEDP Live signaler | Maksimer profitt med Getagraph.com

KJøP 1413 min ago

@ $394.44

Utstedt: 30 apr 2024 @ 17:52

Avkastning: -1.61%

Forrige signal: apr 25 - 18:18

Forrige signal: Selg

Avkastning: 1.65 %

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 17:24):

Stats
Dagens volum	40 646.00
Gjennomsnittsvolum	284 201
Markedsverdi	12.02B
EPS	$0 ( 2024-04-22 )
Neste inntjeningsdato	( $2.50 ) 2024-07-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	39.64
ATR14	$4.34 (1.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-31	Kraft Robert O.	Buy	72	Common Stock
2024-03-31	Kraft Robert O.	Sell	72	Restricted Stock Unit
2024-03-31	Mccarthy Cornelius P. Iii	Buy	63	Common Stock
2024-03-31	Mccarthy Cornelius P. Iii	Sell	63	Restricted Stock Unit
2024-03-31	Carley Brian T	Buy	79	Common Stock

INSIDER POWER
-94.48
Last 100 transactions
Buy: 69 002 \| Sell: 2 472 032

Volum Korrelasjon

Lang: 0.67 (moderate)

Kort: 0.92 (very strong)

Signal:(47) Expect same movement, but be aware

Medpace Holdings Inc Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Medpace Holdings Inc Korrelasjon - Valuta/Råvare

-0.74
( moderate negative )

-0.71
( moderate negative )

0.74
( moderate )

-0.66
( moderate negative )

0.33
( neutral )

Medpace Holdings Inc Økonomi

Annual	2023
Omsetning:	$1.89B
Bruttogevinst:	$524.51M (27.81 %)
EPS:	$9.20

FY	2023
Omsetning:	$1.89B
Bruttogevinst:	$524.51M (27.81 %)
EPS:	$9.20

FY	2022
Omsetning:	$1.46B
Bruttogevinst:	$432.44M (29.62 %)
EPS:	$7.57

FY	2021
Omsetning:	$1.14B
Bruttogevinst:	$328.16M (28.73 %)
EPS:	$5.08

Financial Reports:

No articles found.

Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.